The relationship between sarcopenia and metabolic dysfunction-associated fatty liver disease among the young and middle-aged populations.

ABSTRACT:

Background

Metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed as a new term for diagnosing fatty liver disease, which is considered to be a multi-systemic disease with multiple extrahepatic manifestations, including sarcopenia. The link between sarcopenia and MAFLD remains uncertain, especially among young and middle-aged adults. Thus, we examined the relationship between MAFLD and sarcopenia in young and middle-aged individuals in this study.

Methods

A total of 2214 individuals with laboratory tests, dual-energy X-ray absorptiometry and ultrasound transient elastography from NHANES 2017-2018 were selected for this study. MAFLD was diagnosed as fatty liver disease with any one of the situations: overweight/obesity, diabetes mellitus, presence of m

SUBMITTER: Feng Z 

PROVIDER: S-EPMC10943823 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature